Analyse Progyny, Inc. (PGNY) — Kairos Score 62/100

À propos de Progyny, Inc.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Informations clés

🕴️ Activité des initiés (90 jours)

14 transactions — 0 achats et 4 ventes déclarés par les dirigeants de Progyny, Inc..

🏦 Hedge Funds

17 fonds institutionnels déclarent une position sur PGNY dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur PGNY.

• Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
• Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.